Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients.
Sattler A, Schrezenmeier E, Weber UA, Potekhin A, Bachmann F, Straub-Hohenbleicher H, Budde K, Storz E, Proß V, Bergmann Y, Thole LM, Tizian C, Hölsken O, Diefenbach A, Schrezenmeier H, Jahrsdörfer B, Zemojtel T, Jechow K, Conrad C, Lukassen S, Stauch D, Lachmann N, Choi M, Halleck F, Kotsch K.
Sattler A, et al. Among authors: schrezenmeier h, schrezenmeier e.
J Clin Invest. 2021 Jul 15;131(14):e150175. doi: 10.1172/JCI150175.
J Clin Invest. 2021.
PMID: 34101623
Free PMC article.